Amit K. Verma

Phone718-430-8761
Emailamit.verma@einsteinmed.org
Websitehttp://www.einstein.yu.edu/faculty/10065/amit-verma/

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Amit K. Verma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

6 Finished

Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
Verma, A. K.
1/1/19 → 6/30/20
Project: Research project
Therapeutic targeting of MDS stem cells
Steidl, U. G. & Verma, A. K.
National Heart, Lung, and Blood Institute
8/20/18 → 6/30/21
Project: Research project
Therapeutic targeting of glutamine metabolism in MDS
Verma, A. K. & Verma, A. K.
4/1/16 → 3/31/21
Project: Research project
Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromes
Verma, A. K. & Verma, A. K.
National Institute of Diabetes and Digestive and Kidney Diseases
9/1/14 → 5/31/18
Project: Research project
The role of Dock4 in normal and aberrant erythropoiesis
Verma, A. K., Wickrema, A., Verma, A. K., Rose, S. A., Rose, S. A., Rose, S. A. & Rose, S. A.
National Heart, Lung, and Blood Institute
9/26/12 → 6/30/17
Project: Research project

9382 Citations
57 h-Index
173 Article
30 Review article
16 Letter
9 Comment/debate
More
- 3 Chapter

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Grivas, P., Khaki, A. R., Wise-Draper, T. M., French, B., Hennessy, C., Hsu, C. Y., Shyr, Y., Li, X., Choueiri, T. K., Painter, C. A., Peters, S., Rini, B. I., Thompson, M. A., Mishra, S., Rivera, D. R., Acoba, J. D., Abidi, M. Z., Bakouny, Z., Bashir, B., Bekaii-Saab, T. & 108 others, Berg, S., Bernicker, E. H., Bilen, M. A., Bindal, P., Bishnoi, R., Bouganim, N., Bowles, D. W., Cabal, A., Caimi, P. F., Chism, D. D., Crowell, J., Curran, C., Desai, A., Dixon, B., Doroshow, D. B., Durbin, E. B., Elkrief, A., Farmakiotis, D., Fazio, A., Fecher, L. A., Flora, D. B., Friese, C. R., Fu, J., Gadgeel, S. M., Galsky, M. D., Gill, D. M., Glover, M. J., Goyal, S., Grover, P., Gulati, S., Gupta, S., Halabi, S., Halfdanarson, T. R., Halmos, B., Hausrath, D. J., Hawley, J. E., Hsu, E., Huynh-Le, M., Hwang, C., Jani, C., Jayaraj, A., Johnson, D. B., Kasi, A., Khan, H., Koshkin, V. S., Kuderer, N. M., Kwon, D. H., Lammers, P. E., Li, A., Loaiza-Bonilla, A., Low, C. A., Lustberg, M. B., Lyman, G. H., McKay, R. R., McNair, C., Menon, H., Mesa, R. A., Mico, V., Mundt, D., Nagaraj, G., Nakasone, E. S., Nakayama, J., Nizam, A., Nock, N. L., Park, C., Patel, J. M., Patel, K. G., Peddi, P., Pennell, N. A., Piper-Vallillo, A. J., Puc, M., Ravindranathan, D., Reeves, M. E., Reuben, D. Y., Rosenstein, L., Rosovsky, R. P., Rubinstein, S. M., Salazar, M., Schmidt, A. L., Schwartz, G. K., Shah, M. R., Shah, S. A., Shah, C., Shaya, J. A., Singh, S. R. K., Smits, M., Stockerl-Goldstein, K. E., Stover, D. G., Streckfuss, M., Subbiah, S., Tachiki, L., Tadesse, E., Thakkar, A., Tucker, M. D., Verma, A. K., Vinh, D. C., Weiss, M., Wu, J. T., Wulff-Burchfield, E., Xie, Z., Yu, P. P., Zhang, T., Zhou, A. Y., Zhu, H., Zubiri, L., Shah, D. P., Warner, J. L. & Lopes, G. L., Jun 2021, In: Annals of Oncology. 32, 6, p. 787-800 14 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML
Jasra, S., Kazemi, M., Shah, N., Chen, J., Fehn, K., Wang, Y., Mantzaris, I., Kornblum, N., Sica, A., Bachier, L. M., Goldfinger, M., Gritsman, K., Braunschweig, I., Steidl, U., Shastri, A. & Verma, A., Dec 2021, In: Experimental Hematology and Oncology. 10, 1, 1.
Research output: Contribution to journal › Letter › peer-review

Open Access
1 Scopus citations
Efficacy of ALK5 inhibition in myelofibrosis
Yue, L., Bartenstein, M., Zhao, W., Ho, W. T., Han, Y., Murdun, C., Mailloux, A. W., Zhang, L., Wang, X., Budhathoki, A., Pradhan, K., Rapaport, F., Wang, H., Shao, Z., Ren, X., Steidl, U., Levine, R. L., Zhao, Z. J., Verma, A. & Epling-Burnette, P. K., Apr 6 2021, In: Journal of Clinical Investigation. 2, 7, e90932.
Research output: Contribution to journal › Article › peer-review

Open Access
18 Scopus citations
Excessive R-loops trigger an inflammatory cascade leading to increased HSPC production
Weinreb, J. T., Ghazale, N., Pradhan, K., Gupta, V., Potts, K. S., Tricomi, B., Daniels, N. J., Padgett, R. A., De Oliveira, S., Verma, A. & Bowman, T. V., Mar 8 2021, In: Developmental cell. 56, 5, p. 627-640.e5
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
First-in-human study of inhaled Azacitidine in patients with advanced non-small cell lung cancer
Cheng, H., Zou, Y., Shah, C. D., Fan, N., Bhagat, T. D., Gucalp, R., Kim, M., Verma, A., Piperdi, B., Spivack, S. D., Halmos, B. & Perez-Soler, R., Apr 2021, In: Lung Cancer. 154, p. 99-104 6 p.
Research output: Contribution to journal › Article › peer-review

Amit K. Verma, M.B.,B.S.

Fingerprint

Network

Dive into details

Cooperative Research Agreements Related to the World Trade Center Health Program (U01)

Therapeutic targeting of MDS stem cells

Therapeutic targeting of glutamine metabolism in MDS

Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromes

The role of Dock4 in normal and aberrant erythropoiesis

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML

Efficacy of ALK5 inhibition in myelofibrosis

Excessive R-loops trigger an inflammatory cascade leading to increased HSPC production

First-in-human study of inhaled Azacitidine in patients with advanced non-small cell lung cancer

Amit K. Verma, M.B.,B.S.

Fingerprint

Network

Grants

Publications